Shared Disease Mechanisms in Neurodevelopmental Disorders: A Cellular and Molecular Biology Perspective

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Neurodevelopmental disorders (NDDs) stem from impaired brain development, encompassing conditions like intellectual disability (ID), autism spectrum disorder (ASD), and ADHD.
• Current treatment development for NDDs is hindered by incomplete understanding of how genetic variations impact cellular functions and their convergence/divergence across disorders.

Purpose of the Study:

• To investigate the genetic overlap between epilepsy, ASD, and other NDDs.
• To identify common cellular and molecular mechanisms underlying these disorders.
• To inform the development of targeted treatments for NDDs, individually or collectively.

Main Methods:

• Review of genetic associations between epilepsy, ASD, and other NDD phenotypes.
• Analysis of genes such as CDKL5, TSC1/2, SCN1a, and TANC2 involved in brain development and function.
• Examination of genotype-phenotype relationships and distinct functional pathways.

Main Results:

• Several genes implicated in epilepsy and ASD play critical roles in brain development but exhibit diverse disease-causing mechanisms.
• Genotype-phenotype correlations reveal how specific genetic variants lead to different NDD outcomes.
• Identified distinct functional pathways through which genes can cause NDDs.

Conclusions:

• Understanding the genetic underpinnings and molecular pathways common to epilepsy, ASD, and NDDs is crucial for advancing therapeutic strategies.
• Investigating shared genetic mechanisms offers potential for developing unified or tailored treatments for a spectrum of neurodevelopmental conditions.